Skip to content

Midds Ankle Fracture

gekoTM Neuromuscular Electrostimulation (NMES) Device, Pilot Feasibility Study Looking at Time to Surgery Study in Patients Requiring Ankle Fixation Following Fracture, Comparison to Matched Retrospective Controls

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02841007
Enrollment
20
Registered
2016-07-21
Start date
2016-07-31
Completion date
2017-02-28
Last updated
2017-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Fracture Requiring Internal Fixation

Brief summary

The geko™ device is indicated for the prevention and treatment of oedema. The aim of this study is to show that recruiting, and performing study assessments in ankle fracture patients requiring surgery to fix their ankle attending the James Cook Hospital is feasible, and to obtain data to support the powering of a larger study to demonstrate the effectiveness of the geko™ device at reducing length of stay for this population of patients. This study will also allow us to assess the acceptability, tolerability and compliance of treatment with the geko device.

Interventions

DEVICEgeko neuromuscular electrostimulation device

Sponsors

Firstkind Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Aged 18-60 years old 2. Clinically and radiologically diagnosed acute ankle fracture that, in the opinion of the treating surgeon, requires operative fixation 3. Able to understand the Patient Information Sheet (PIS) and willing to sign the written Informed Consent Form. 4. Able and willing to follow the protocol requirements.

Exclusion criteria

1. Has a pacemaker 2. Morbid Obesity (BMI Index \>40kg/m2). 3. Patients who on presentation to hospital are known to be pregnant. 4. Clinically significant co-morbidities that need to be treated prior to surgical intervention and could therefore impact upon time to theatre 5. History or signs of previous deep or superficial vein thrombosis/pulmonary embolism. 6. Varicosities, ulceration or erosion around the area of the leg where the study device would be fitted 7. Diabetic 8. Already taking part in a clinical study, or has so within the last 8 weeks 9. None responder to geko™ device

Design outcomes

Primary

MeasureTime frame
Feasibility to recruit n=20 ankle fracture patients in trauma setting within 4 months4 months
Time to readiness for surgery0-~7days

Secondary

MeasureTime frame
Oedema reduction in prospective geko™ subjects prior to surgery, by two circumferential measures using tape measures built into the patients plaster cast0-~7days
Adverse events, including the need for secondary surgery or additional treatment, serious adverse eventsstudy duration up to ~14days

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026